Description

For years, cell biologists have relied on classic growth media, like Dulbecco Modified Eagle's Medium (DMEM), MCDB-105 and RPMI 1640. With scores of publications to their names, these time-proven standbys continue to form a sound foundation for in vitro culture experiments.
Add supplements such as fetal bovine serum, growth factors, trace elements, and /or antibiotics, depending on cell type. The media are buffered and sterile filtered, and tested to  stringent quality standards. 
 
Classic Cell Culture Media, e.g. Dulbecco Modified Eagle's Medium (DMEM), MCDB-105 and RPMI 1640.

Details

Need help choosing?  See our Media Selection Guide

Products

Product Size CAT.# Price Quantity
Dulbecco's Modified Eagle's Medium: 1X DMEM, 4.25g/L Glucose Size: 500 ml CAT.#: 180-500 Price: $25.63
-+
MCDB 105 Medium, unmodified: Unmodified MCDB 105 Medium Size: 500 ml CAT.#: 117-500 Price: $48.43
-+
RPMI 1640 Medium, w/L-Glutamine: RPMI 1640 Medium, with L-Glutamine, without HEPES Size: 500 ml CAT.#: 185-500 Price: $26.65
-+

Related Products

Product Size CAT.# Price Quantity
L-Glutamine: Amino acid supplement for cell culture media, important for cell growth & function Size: 100 ml CAT.#: 013-100 Price: $33.00
-+

Publications

2017
Liao, Y., Y. Deng, J. Liu, Z. Ye, Z. You, S. Yao and S. He. 2017MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expressionGynecologic Oncology, 143:655-663. 
Muranen, T., M.Iwanicki, N. Curry, J. Hwang, C. DuBois,J. Coloff, D. Hitchcock, C. Clish, J. Brugge and N. Kalaany. 2017. Starved epithelial cells uptake extracellular matrix for survival. Nature Commumicatins, 8: doi:10.1038/ncomms13989.
2016
Guo, T., G. Shen, X. Tong, G. Zhou, Y. Wan, D. Li, X. Dai, X. Sun and Y. Tian. 2016. miR-125b expression in ovarian cancer cell lines. Int J Clin Exp Pathathol, 9:5267-5275.
Liao, Y., Y. Deng, J. Liu, Z. Ye, Z. You, S. Yao and S. He. 2016. MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression. Gynecologic Oncology, 143:655-663.
2015
Wu, B., S. Shrestha, K. Ong, D. Johns, L. Dunn, L. Hou, P. Barter and K. Rye. 2015. Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis. Intl J Cardiol, 199:204-212.
Zhu, Z., L. Song, J. He, Y. Sun, X. Liu and X. Zou. 2015. Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer. Int J Clin Exp Pathol, 8:10082-10091.
2014
Davidowitz, R., L. Selfors, M. Iwanicki, K. Elias, A. Karst, H. Piao, T. Ince, M. Drage, J. Dering, G. Konecny, U. Matulonis, G. Mills, D. Slamon, R. Drapkin and J. Brugge. 2014. Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. J Clin Invest, 124:2611–2625.
2012
Meng, E., B. Long, P. Sullivan, S. McClellan, M. Finan, E. Reed, L. Shevde, and R. Rocconi. 2012. CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin & Exp Met, 29:939-948.
Moffett, J., L.M. Fray, and N.J. Kubat. 2012. Activation of endogenous opioid gene expression in human keratinocytes and fibroblasts by pulsed radiofrequency energy fields. Journal of pain research. 5:347.
2011
Iwanicki, M., R. Davidowitz, M. Ng, A. Besser, T. Muranen, M. Merritt, G. Danuser, T. Ince, and J. Brugge. 2011. Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium. Cancer Discovery, 1:144.
Ray, A., E. Meng, E. Reed, L. Shevde, andn R. Rocconi. 2011. Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. Intl J Oncol, 39:797-804.
2009
Konecny, G., R. Glas, J. Dering, K. Manivong, J. Qi, R. Finn, G. Yang, K. Hong, C. Ginther, B. Winterhoff, G. Gao, J. Brugge, and D. Slamon. 2009. Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. British J Cancer, 101:1699-1708